letermovir

Products Letermovir was approved in the United States in 2017 and in the EU and many countries in 2018 in tablet form and as an intravenous solution for injection (Prevymis). Structure and properties Letermovir (C29H28F4N4O4, Mr = 572.6 g/mol) Effects Letermovir (ATC J05AX18) has antiviral properties. The effects are due to inhibition of the CMV … Letermovir